315 related articles for article (PubMed ID: 29878849)
1. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
[TBL] [Abstract][Full Text] [Related]
2. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
3. Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy.
Dell'Oro M; Wilson P; Short M; Hua CH; Merchant TE; Bezak E
Med Phys; 2022 Jan; 49(1):742-755. PubMed ID: 34796509
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
5. Assessing the shift of radiobiological metrics in lung radiotherapy plans using 2D gamma index.
Chaikh A; Balosso J
Transl Lung Cancer Res; 2016 Jun; 5(3):265-71. PubMed ID: 27413708
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
7. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
8. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
10. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours.
Lideståhl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
Phys Med; 2019 Apr; 60():120-126. PubMed ID: 31000071
[TBL] [Abstract][Full Text] [Related]
11. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
12. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).
Luxton G; Keall PJ; King CR
Phys Med Biol; 2008 Jan; 53(1):23-36. PubMed ID: 18182685
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
14. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
16. NTCP modeling analysis of acute hematologic toxicity in whole pelvic radiation therapy for gynecologic malignancies - A dosimetric comparison of IMRT and spot-scanning proton therapy (SSPT).
Yoshimura T; Kinoshita R; Onodera S; Toramatsu C; Suzuki R; Ito YM; Takao S; Matsuura T; Matsuzaki Y; Umegaki K; Shirato H; Shimizu S
Phys Med; 2016 Sep; 32(9):1095-102. PubMed ID: 27567089
[TBL] [Abstract][Full Text] [Related]
17. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
[TBL] [Abstract][Full Text] [Related]
18. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy.
Moteabbed M; Yock TI; Depauw N; Madden TM; Kooy HM; Paganetti H
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):190-198. PubMed ID: 27084640
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy.
Chen M; Pang B; Zeng Y; Xu C; Chen J; Yang K; Chang Y; Yang Z
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38718814
[No Abstract] [Full Text] [Related]
20. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
